Ipilimumab Biosimilar - Research Grade
Catalogue Number: ICH4025-ICB
| Manufacturer: | IchorBio |
| Type: | Recombinant Monoclonal |
| Alias: | Ctla4, Cytotoxic T-lymphocyte protein 4, CD152 |
| Shipping Condition: | Blue Ice |
| Unit(s): | 10 mg, 20 mg, 5 mg, 50 mg, 1 mg, 100 mg, 200 mg |
| Host name: | |
| Clone: | |
| Isotype: | IgG1, kappa |
| Immunogen: |
Description
Description: Ipilimumab biosimilar is a recombinant, human monoclonal antibody that binds to the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Ipilimumab biosimilar is an IgG1 kappa immunoglobulin with an approximate molecular weight of 148 kDa. Ipilimumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture.
Additional Text
Uniprot ID
P16410
Purification
Protein A/G Purified
Gene ID
1493
Gene Name
CTLA4
Concentration
1-5 mg/ml
Antibody Clonality
Recombinant Monoclonal
Storage Note
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
ICH4025 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations